BS

ClearScale Welcomes Steven Russell as New Chief Financial Officer

Retrieved on: 
Thursday, November 9, 2023
Harvard Business School, Intelligence, BS, MBA, Engineering, Growth, Interim, Cloud computing, AWS, CFO, SAN, Management

SAN FRANCISCO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearScale , a leading AWS Premier Tier Services Partner, announced the appointment of Steven Russell as its Chief Financial Officer (CFO).

Key Points: 
  • SAN FRANCISCO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearScale , a leading AWS Premier Tier Services Partner, announced the appointment of Steven Russell as its Chief Financial Officer (CFO).
  • In this role, Russell will direct and oversee the company’s financial strategy and operations.
  • “I'm delighted to join ClearScale as CFO to help drive growth at an exciting time in the company’s transformation,” Russell said.
  • “We are delighted that Steven is joining ClearScale,” said Jimmy Chui, Interim Chief Executive Officer at ClearScale.

ROHM’s New Ultra-High-Speed Gate Driver IC: Maximizing the Performance of GaN Devices

Retrieved on: 
Wednesday, November 8, 2023
Internet of things, ROHM, Department of Electrical Engineering and Information Technology of TU Darmstadt, Rohm, APEX, National Chiao Tung University, NCU, National Taipei University of Technology, BS, DC-DC, JJAP, AC-DC, Research, WLCSP, National Taipei University, Gallium nitride, Pulse, MS, University, Chang Gung University, Japanese Journal of Applied Physics, National Central University, Electricity, Miniaturization, Applied Physics Express, Silicon, Electric motor, Electronics, Lidar

This was facilitated through a deep understanding of GaN technology and the continuing pursuit of gate driver performance.

Key Points: 
  • This was facilitated through a deep understanding of GaN technology and the continuing pursuit of gate driver performance.
  • As these applications require the use of high-speed switching devices, in conjunction with the release of GaN devices, ROHM developed an ultra-high-speed gate driver IC that maximizes GaN performance.
  • As GaN devices are sensitive towards gate input overvoltage, ROHM has developed a unique method to suppress the gate voltage overshoots and has implemented it into this driver.
  • On the other hand, to demonstrate the performance of GaN devices, gate driver IC that enable high-speed switching while taking into account the low drive voltage of GaN HEMTs are essential.

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

Retrieved on: 
Wednesday, November 8, 2023
University of Washington Department of Global Health, Stanford University, Bio, Infection, Therapy, Viral, Biotechnology, Herpes simplex virus, BS, MD, Publication, Doctor of Philosophy, Gilead Sciences, Sofosbuvir, University, Assembly, HCV, Virology, Chemistry, Patient, HDV, HBV, SAN, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer. Dr. Gaggar is an infectious disease specialist and seasoned executive whose experience has focused on the development of new therapies in viral diseases including chronic hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) infections.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer.
  • “We are excited to have Dr. Gaggar join Assembly Bio’s leadership team at an incredibly important time for the organization,” said Jason Okazaki, chief executive officer and president.
  • Dr. Gaggar was a clinical fellow in infectious diseases at the University of California, San Francisco, where he also served as chief resident.
  • He received his MD and PhD from the University of Washington and his BS in chemistry from Stanford University.

Civitas Resources Announces Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 7, 2023
Energy, Natural Resources, Other Natural Resources, Oil, Gas, Permian, Devon Energy, Virginia University, Wells, West Virginia University, Noble Energy, BP, Chemical engineering, Civitas, Technical director, BS, G&A, Acquisition, Senior, Texas A&M University, Natural gas, Investment, WTI, Petroleum, Airline, Management, Safety, Health, LNG

Net crude oil, natural gas, and natural gas liquids revenue in the third quarter of 2023 was $1.0 billion, compared to $660.5 million in the second quarter of 2023 as average daily sales volumes increased 36% and realized prices increased 15%.

Key Points: 
  • Net crude oil, natural gas, and natural gas liquids revenue in the third quarter of 2023 was $1.0 billion, compared to $660.5 million in the second quarter of 2023 as average daily sales volumes increased 36% and realized prices increased 15%.
  • Lease operating expense for the third quarter of 2023, on a unit basis, increased to $4.37 per Boe from $3.24 per Boe in the second quarter of 2023, reflecting the addition of two months of Permian operations.
  • On a per unit basis, the Company's G&A expenses decreased 21% sequentially from $2.12 per Boe in the second quarter of 2023 to $1.67 per Boe in the third quarter of 2023.
  • Civitas is expanding its leadership team with two key additions:
    Sam Blatt will lead Civitas' Permian operations as Senior Vice President - Permian.

GTCR Announces Promotions and New Leadership for Portfolio Resources Group

Retrieved on: 
Tuesday, November 7, 2023
University, KPI-driven code analysis, UCLA School of Law, JD, BS, PRG, BSBA, GTCR, CommerceHub, Entrepreneurship, Investment, Information management, Law, Wharton School of the University of Pennsylvania, Environment, Portfolio, Growth, Widener University Commonwealth Law School, TMT, Security (finance), Management

CHICAGO, Nov. 7, 2023 /PRNewswire/ -- GTCR, a leading private equity firm, announced today the promotions of Jeff Wright to Managing Director and Cameron Rouzer to Principal, along with the promotions of Travis Krueger and Joseph Rubino to serve as Co-Heads of the firm's Portfolio Resources Group (PRG). 

Key Points: 
  • GTCR formed the PRG in 2022 to build intellectual capital and expertise in specific functional areas to further support portfolio company growth and performance.
  • PRG comprises a team of experienced professionals specializing in critical business fields, who work as resources for GTCR portfolio management teams.
  • Mr. Krueger, who joined GTCR in 2005, will also continue to lead GTCR's efforts in Portfolio Data and Analytics.
  • "The appointment of Travis and Joe as Co-Heads of the Portfolio Resources Group is a testament to their leadership and the impact that we are already achieving through the PRG.

Lexicon Strengthens Management Team With Two New Executives

Retrieved on: 
Tuesday, October 31, 2023
Knowledge, National Investor Relations Institute, Professional corporation, Bristol Myers Squibb, Melinta Therapeutics, Policy, AbbVie, Lexicon, Therapy, Ophthalmology, Actavis, Intercept, BS, Seton Hall University, Ozanimod, University, Amarin, Warner Chilcott, MBA, Ladenburg Thalmann, Alemtuzumab, Allergan, Business administration, Marketing, Wall Street, Watson Labs, Villalba v Merrill Lynch & Co Inc, Sclerosis, Heart failure, Intercept Pharmaceuticals, Pharmaceutical industry

THE WOODLANDS, Texas, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Matthew Cullen is joining the company as vice president of value and access, effective November 1, 2023, and Lisa DeFrancesco will join as head of investor relations and corporate strategy, effective November 13, 2023.

Key Points: 
  • Mr. Cullen brings Lexicon more than 35 years of industry experience in market access and sales leadership.
  • Before joining Lexicon, Matt served as vice president, value, access and policy at Apellis Pharmaceuticals where he led the market access launch of rare disease drug EMPAVELI® (pegcetacoplan) and ophthalmology drug SYFOVRE® (pegcetacoplan injection).
  • His responsibilities included pricing and contracting, payer strategy and marketing, corporate and strategic account management, field reimbursement, trade and distribution, and training.
  • Prior to Apellis, Mr. Cullen led strategic payer marketing and access teams at Bristol-Myers Squibb for ELIQUIS® (apixaban) and ORENCIA® (abatacept).

Armco Barrier Supplies Fabricating and Selling Armco Barriers To Multiple Industries for Over 20 Years

Retrieved on: 
Tuesday, October 31, 2023
Traffic, Crash, Barrier, BS, Pedestrian, Health, Maintenance, Airport, School, Occupational safety and health, RSJ, Longevity, Renewable energy, Road, Safety, AK Steel Holding

Smeeton Westerby, United Kingdom, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Armco Barriers Supplies, a family-run company dedicated to providing robust and reliable Armco Barrier solutions at competitive rates, is thrilled to announce its celebration of fabricating and selling Armco Barriers to multiple industries for over 20 years.

Key Points: 
  • Smeeton Westerby, United Kingdom, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Armco Barriers Supplies, a family-run company dedicated to providing robust and reliable Armco Barrier solutions at competitive rates, is thrilled to announce its celebration of fabricating and selling Armco Barriers to multiple industries for over 20 years.
  • At Armco Barrier Supplies, we’re proud to have built our reputation as being the honest, straightforward and reliable choice for our customers on all things Armco Barrier related,” said a spokesperson for Armco Barrier Supplies.
  • The company’s Armco Barrier Posts are crucial components of the Armco Barrier system, providing support and structure to the barriers.
  • With options of concrete barriers, plastic barriers, and metal barriers, Armco Barriers also come in an assortment of sizes that offer varying levels of protection.

Bumble Inc. Announces Leadership Succession Plan for Company’s Next Chapter of Growth

Retrieved on: 
Monday, November 6, 2023
Social Media, Communications, Cloud, EVP, Policy, NYSE, Development, Slack, Economics, Life, BS, Microsoft, Commerce, Lidiane Jones, Jones, University, Friends, Growth, Inc., Executive, Machine learning, Whitney, Woman, CRM, Safety, Marketing, GM, Computer science, Management, Bumble, Salesforce

Bumble Inc. (NASDAQ: BMBL) today announced a leadership succession plan for the Company’s next chapter of growth.

Key Points: 
  • Bumble Inc. (NASDAQ: BMBL) today announced a leadership succession plan for the Company’s next chapter of growth.
  • Wolfe Herd founded Bumble in 2014 with the goal of creating an empowering online dating space for women.
  • Under Wolfe Herd’s leadership, Bumble has become one of the world’s leading networking apps, enabling members to connect with confidence whether dating, networking or meeting friends online.
  • Bumble Inc. has also become known as a global brand that champions women’s safety online.

Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize

Retrieved on: 
Thursday, November 2, 2023
Science, Health, Neurology, Research, Sequence, Feinstein Institutes for Medical Research, Inflammation, Karolinska Institute, Doctor of Philosophy, Rheumatoid arthritis, Biomedical sciences, Shock, Immunity, Neuroscience, Boston University, Neurosurgery, Death, Rockefeller University, Medical research, Hope, Nobel Committee, Vagus nerve stimulation, Reflex, Cytokine, Boston College, Royal Academies for Science and the Arts of Belgium, Northwell Health, Medicine, Credit, UNESCO Science Prize, Patient, Vagus nerve, Septic shock, Human, University Medical Center, BS, Laboratory, Travel, Olivia Wigzell, Chemistry, Survival, Education, Royal Academy of Arts, Water, Multimedia, Dana, Engineering, Rockefeller, Student, Dana Foundation, Sepsis, Inflammatory bowel disease, Nursing, Pharmaceutical industry, Medical device, MD

The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Key Points: 
  • The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
  • Dr. Tracey will travel to Stockholm, Sweden, to receive the prize, which includes $100,000, and deliver a lecture on December 1.
  • View the full release here: https://www.businesswire.com/news/home/20231102553265/en/
    Dr. Kevin J. Tracey has been named awardee of the 2023 Hans Wigzell Research Foundation's Science Prize.
  • “The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases,” said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Coca-Cola Bottlers’ Sales & Services Company, LLC Names Kimberly Green Reynolds as Chief Procurement Officer

Retrieved on: 
Thursday, November 2, 2023
Retail, Consumer, Women, Manufacturing, Other Manufacturing, Food, Beverage, Knowledge, United States Senate Agriculture Subcommittee on Commodities, Risk Management, and Trade, Corporation Service Company, Bottler, BS, Coca-Cola, University, Diageo, Multimedia, Agricultural education, Clemson University, ADM (company), Agriculture, Bottled water

Coca-Cola Bottlers’ Sales & Services Company (CCBSS), a limited liability company owned by nearly 70 independent North American Coca-Cola bottlers, announced today Kimberly Green Reynolds has been named as the company’s Chief Procurement Officer reporting to Brandi Shortt, CCBSS President and CEO.

Key Points: 
  • Coca-Cola Bottlers’ Sales & Services Company (CCBSS), a limited liability company owned by nearly 70 independent North American Coca-Cola bottlers, announced today Kimberly Green Reynolds has been named as the company’s Chief Procurement Officer reporting to Brandi Shortt, CCBSS President and CEO.
  • Kimberly will have further accountability to the Bottler Procurement Advisory Committee and the CCBSS Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20231102319124/en/
    As Chief Procurement Officer, Kimberly will lead the CCBSS Procurement organization with ultimate responsibility for more than $70 billion in procurement spend.
  • Prior to joining the Coca-Cola System, Kimberly built an impressive 15-year career working in the areas of procurement and business transformation.